Anemia in the critically ill

Critical Care Clinics

Volumn 20, Issue 2, 2004, Pages 159-178

  Shander, Aryeh ^a,b  

^a ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; CYTOKINE; IRON; PARACETAMOL; PENICILLIN G; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SULFANILAMIDE;

ANEMIA; BLEEDING; BLOOD STORAGE; CANCER; CANCER CHEMOTHERAPY; CRITICAL ILLNESS; DIALYSIS; ERYTHROPOIESIS; HEMATOCRIT; HEMODILUTION; HEMOLYTIC ANEMIA; HUMAN; INFLAMMATION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY FAILURE; MACROPHAGE; PRIORITY JOURNAL; REVIEW;

ANEMIA; BLOOD LOSS, SURGICAL; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; INFLAMMATION; UNITED STATES;

EID: 2342616784     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2004.01.002     Document Type: Review

References (86)

1. Krafte-Jacobs B. Anemia of critical illness and erythropoietin deficiency. Intensive Care Med. 23:1997;137-138
2. Lee G.R. The anemia of chronic disease. Semin Hematol. 20:1983;61-80
3. Means R.T. Jr. Advances in the anemia of chronic disease. Int J Hematol. 70:1999;7-12
4. Groeger J.S., Guntupalli K.K., Strosberg M., Halpern N., Raphaely R.C., Cerra F., et al. Descriptive analysis of critical care units in the United States: patient characteristics and intensive care unit utilization. Crit Care Med. 21:1993;279-291
5. Vincent J.L., Baron J.F., Reinhart K., Gattinoni L., Thijs L., Webb A., et al. Anemia and blood transfusion in critically ill patients. JAMA. 288:2002;1499-1507
6. Tchekmedyian N.S. Anemia in cancer patients: significance, epidemiology, and current therapy. Oncology (Huntingt). 16:2002;17-24
7. Harris J.K., Harris J.W. The red cell: production, metabolism, destruction: normal and abnormal. 2nd edition:1970;Harvard University Press, Boston
8. Guyton A.C. Textbook of medical physiology. 7th edition:1986;WB Saunders, Philadelphia
9. Salsbury D.C. Anemia of prematurity. Neonatal Netw. 20:2001;13-20
10. Cazzola M. How and when to use erythropoietin. Curr Opin Hematol. 5:1998;103-108
11. Krafte-Jacobs B., Levetown M.L., Bray G.L., Ruttimann U.E., Pollack M.M. Erythropoietin response to critical illness. Crit Care Med. 22:1994;821-826
12. Rogiers P., Zhang H., Leeman M., Nagler J., Neels H., Melot C., et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med. 23:1997;159-162
13. Shorr A.F., Thomas S.J., Alkins S.A., Fitzpatrick T.M., Ling G.S. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest. 121:2002;1262-1268
14. Pettila V., Hynninen M., Takkunen O., Kuusela P., Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med. 28(9):2002;1220-1225
15. Rodriguez R.M., Corwin H.L., Gettinger A., Corwin M.J., Gubler D., Pearl R.G. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 16:2001;36-41
16. Faquin W.C., Schneider T.J., Goldberg M.A. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood. 79:1992;1987-1994
17. von Ahsen N., Muller C., Serke S., Frei U., Eckardt K.U. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med. 27:1999;2630-2639
18. Corwin H.L., Gettinger A., Rodriguez R.M., Pearl R.G., Gubler K.D., Enny C., et al. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med. 27:1999;2346-2350
19. Jongen-Lavrencic M., Peeters H.R., Rozemuller H., Rombouts W.J., Martens A.C., Vreugdenhil G., et al. IL-6-induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammations. Clin Exp Immunol. 103:1996;328-334
20. Weiss G., Wachter H., Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol Today. 16:1995;495-500
21. van Iperen C.E., Kraaijenhagen R.J., Biesma D.H., Beguin Y., Marx J.J., van de Wiel A. Iron metabolism and erythropoiesis after surgery. Br J Surg. 85:1998;41-45
22. Fuchs D., Hausen A., Reibnegger G., Werner E.R., Werner-Felmayer G., Dierich M.P., et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol. 46:1991;65-70
23. Haile D.J. Regulation of genes of iron metabolism by the iron-response proteins. Am J Med Sci. 318:1999;230-240
24. Esparza I., Brock J.H. Release of iron by resident and stimulated mouse peritoneal macrophages following ingestion and degradation of transferrin-antitransferrin immune complexes. Br J Haematol. 49:1981;603-614
25. Kleber E.E., Lynch S.R., Skikne B., Torrance J.D., Bothwell T.H., Charlton R.W. Erythrocyte catabolism in the inflammatory peritoneal monocyte. Br J Haematol. 39:1978;41-54
26. Weiss G. Iron and anemia of chronic disease. Kidney Int Suppl. 69:1999;S12-S17
27. Wingard R.L., Parker R.A., Ismail N., Hakim R.M. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis. 25:1995;433-439
28. Fishbane S., Kowalski E.A. The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. Semin Dial. 13:2000;381-384
29. Bellamy M.C., Gedney J.A. Unrecognised iron deficiency in critical illness. Lancet. 352:1998;1903
30. Erslev A.J. Erythropoietin and anemia of cancer. Eur J Haematol. 64:2000;353-358
31. Gyftaki E., Kesse-Elia M., Mavrikakis M., Papadoyanakis N. Iron metabolism and red cell survival in uremic patients. Acta Haematol. 47:1972;200-209
32. Higgins M.R., Grace M., Ulan R.A., Silverberg D.S., Bettcher K.B., Dossetor J.B. Anemia in hemodialysis patients. Arch Intern Med. 137:1977;172-176
33. Biesma D.H., Van de Wiel A., Beguin Y., Kraaijenhagen R.J., Marx J.J. Postoperative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest. 25:1995;383-389
34. Heyland D.K., Cook D.J., King D., Kernerman P., Brun-Buisson C. Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. Crit Care Med. 24:1996;517-524
35. Marik P.E., Sibbald W.J. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 269:1993;3024-3029
36. Hebert P.C., Wells G., Blajchman M.A., Marshall J., Martin C., Pagliarello G., et al. A multi-center, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 340:1999;409-417
37. Vamvakas E., Kaplan H.S. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion. 33:1993;111-118
38. Vamvakas E.C., Carven J.H. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion. 39:1999;701-710
39. Claridge J.A., Sawyer R.G., Schulman A.M., McLemore E.C., Young J.S. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg. 68:2002;566-572
40. Farion K.J., McLellan B.A., Boulanger B.R., Szalai J.P. Changes in red cell transfusion practice among adult trauma victims. J Trauma. 44:1998;583-587
41. Friederich P.W., Henny C.P., Messelink E.J., Geerdink M.G., Keller T., Kurth K.H., et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet. 361:2003;201-205
42. Paganini E.P. Overview of anemia associated with chronic renal disease: primary and secondary mechanisms. Semin Nephrol. 9:1989;3-8
43. Paganini E.P., Garcia J., Abdulhadi M., Lathim D., Giesman J., Weick J.K. The anemia of chronic renal failure. Overview and early erythropoietin experience. Cleve Clin J Med. 56:1989;79-86
44. Naets J.P. Hematologic disorders in renal failure. Nephron. 14:1975;181-194
45. Neimark M.I. Changes in the oxygen transport function in patients with chronic kidney failure during hemodialysis. Anesteziol Reanimatol. Jan-Feb(1):1989;14-17
46. Gordon M.S. Managing anemia in the cancer patient: old problems, future solutions. Oncologist. 7:2002;331-341
47. Lee W.R., Berkey B., Marcial V., Fu K.K., Cooper J.S., Vikram B., et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys. 42:1998;1069-1075
48. Saba H. Anemia and cancer patients: introduction and overview. Cancer Control. 5(2 Suppl):1998;225-456
49. Mercadante S., Gebbia V., Marrazzo A., Filosto S. Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev. 26:2000;303-311
50. Kumar P. Impact of anemia in patients with head and neck cancer. Oncologist. 5(Suppl 2):2000;13-18
51. Fyles A.W., Milosevic M., Pintilie M., Syed A., Hill R.P. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol. 57:2000;13-19
52. Harrison L.B., Shasha D., White C., Ramdeen B. Radiotherapy-associated anemia: the scope of the problem. Oncologist. 5(Suppl 2):2000;1-7
53. Lane P., Gross S. Hemoglobin as a chariot for NO bioactivity. Nat Med. 8:2002;657-658
54. McMahon T.J., Moon R.E., Luschinger B.P., Carraway M.S., Stone A.E., Stolp B.W., et al. Nitric oxide in the human respiratory cycle. Nat Med. 8:2002;711-717
55. Zhu H., Jackson T., Bunn H.F. Detecting and responding to hypoxia. Nephrol Dial Transplant. 17(Suppl 1):2002;3-7
56. Semenza G.L. Perspectives on oxygen sensing. Cell. 98:1999;281-284
57. Kaelin W.G. Jr. How oxygen makes its presence felt. Genes Dev. 16:2002;1441-1445
58. Murray J.F., Escobar E., Rapaport E. Effects of blood viscosity on hemodynamic responses in acute normovolemic anemia. Am J Physiol. 216:1969;638-642
59. Woodson R.D., Auerbach S. Effect of increased oxygen affinity and anemia on cardiac output and its distribution. J Appl Physiol. 53:1982;1299-1306
60. Messmer K. Blood rheology factors and capillary blood flow. 1991;Springer-Verlag, Berlin
61. Wilkerson D.K., Rosen A.L., Sehgal L.R., Gould S.A., Sehgal H.L., Moss G.S. Limits of cardiac compensation in anemic baboons. Surgery. 103:1988;665-670
62. Hagl S., Heimisch W., Meisner H., Erben R., Baum M., Mendler N. The effect of hemodilution on regional myocardial function in the presence of coronary stenosis. Basic Res Cardiol. 72:1977;344-364
63. Geha A.S., Baue A.E. Graded coronary stenosis and coronary flow during acute normovolemic anemia. World J Surg. 2:1978;645-651
64. Opelz G., Sengar D.P., Mickey M.R., Terasaki P.I. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 5:1973;253-259
65. Heiss M.M., Mempel W., Delanoff C., Jauch K.W., Gabka C., Mempel M., et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol. 12:1994;1859-1867
66. Tegtmeier G.E. Post-transfusion cytomegalovirus infections. Arch Pathol Lab Med. 113:1989;236-245
67. Bordin J.O., Bardossy L., Blajchman M.A. Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of white cell reduction on allogeneic alloimmunization. Transfusion. 33:1993;798-801
68. Bordin J.O., Heddle N.M., Blajchman M.A. Biologic effects of leukocytes present in transfused cellular blood products. Blood. 84:1994;1703-1721
69. Bordin J.O., Blajchman M.A. Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy. Hematol Oncol Clin North Am. 9:1995;205-218
70. Murphy M.F. New variant Creutzfeldt-Jakob disease (nvCJD): the risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components. Transfus Med Rev. 13:1999;75-83
71. Thurer R.L., Luban N.L., AuBuchon J.P., Silver H., McCarthy L.J., Dzik S., et al. Universal WBC reduction. Transfusion. 40:2000;751-752
72. Houbiers J.G., Brand A., van de Watering L.M., Hermans J., Verwey P.J., Bijnen A.B., et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 344:1994;573-578
73. van de Watering L.M., Hermans J., Houbiers J.G., van den Broek P.J., Bouter H., Boer F., et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 97:1998;562-568
74. Berezina T.L., Zaets S.B., Morgan C., Spillert C.R., Kamiyama M., Spolarics Z., et al. Influence of storage on red blood cell rheological properties. J Surg Res. 102:2002;6-12
75. Purdy F.R., Tweeddale M.G., Merrick P.M. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth. 44:1997;1256-1261
76. Martin C. Age of transfused red blood cells is associated with increased ICU length of stay. Clin Invest Med. 17:1994;124
77. Lorente J.A., Landin L., De Pablo R., Renes E., Rodriguez-Diaz R., Liste D. Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med. 21:1993;1312-1318
78. Machiedo G.W., Powell R.J., Rush B.F. Jr., Swislocki N.I., Dikdan G. The incidence of decreased red blood cell deformability in sepsis and the association with oxygen free radical damage and multiple-system organ failure. Arch Surg. 124:1989;1386-1389
79. Hoeft A., Wietasch J.K., Sonntag H., Kettler D. Theoretical limits of permissive anemia. Zentralbl Chir. 120:1995;604-613
80. Corwin H.L., Krantz S.B. Anemia of the critically ill: acute anemia of chronic disease. Crit Care Med. 28:2000;3098-3099
81. Corwin H.L., Gettinger A., Pearl R.G., Fink M.P., Levy M.M., Shapiro M.J., et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 288:2002;2827-2835
82. Gabriel A., Kozek S., Chiari A., Fitzgerald R., Grabner C., Geissler K., et al. High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma. 44:1998;361-367
83. van Iperen C.E., Gaillard C.A., Kraaijenhagen R.J., Braam B.G., Marx J.J., van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med. 28:2000;2773-2778
84. Monk T.G., Goodnough L.T., Brecher M.E., Colberg J.W., Andriole G.L., Catalona W.J. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology. 91:1999;24-33
85. Goodnough L.T., Shander A., Brecher M.E. Transfusion medicine: looking to the future. Lancet. 361(9352):2003;161-169
86. Moskowitz D.M., Perelman S.I., Cousinesau K.M., Klein J.J., Shander A., Margolis E.J., et al. Multidisciplinary management of a Jehovah's Witness patient for the removal of a renal cell carcinoma extending into the right atrium. Can J Anaesth. 49(4):2002;402-408